| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Total revenue | 14,597 | 20,359 | 14,625 | |
| Cost of revenue | 11,227 | 14,482 | 11,243 | |
| Gross profit | 3,370 | 5,877 | 3,382 | |
| Research and development expense | 1,082 | 955 | 1,018 | |
| Selling, general and administrative expense | 3,069 | 3,012 | 2,108 | |
| Net (loss) income from operations | -781 | 1,910 | 256 | |
| Other income, net | - | 1,234 | - | |
| Interest expense | - | - | 176 | |
| Interest expense, net | -339 | -87 | - | |
| Net (loss) income before provision for income taxes | -1,120 | 3,057 | 80 | |
| Provision for income taxes | - | 390 | - | |
| Net (loss) income | -1,120 | 2,667 | 80 | |
| Net (loss) income per share-basic | -0.02 | 0.04 | 0 | |
| Net (loss) income per share-diluted | -0.02 | 0.04 | 0 | |
| Weighted average number of basic common shares outstanding | 70,500,925 | 70,200,039 | 70,103,279 | |
| Weighted average number of diluted common shares outstanding | 70,500,925 | 72,580,679 | 72,632,116 | |
SOLESENCE, INC. (SLSN)
SOLESENCE, INC. (SLSN)